Stocktoria
Adicet Bio, Inc. ACET
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-01-26
Adicet Bio, Inc. statistics & valuation
Market cap$78.2M
P / B0.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -60.7% | -53.2% | -68.8% | -21.1% | -18.3% |
| Return on equity | -73.4% | -62.8% | -83.8% | -23.9% | -20.5% |
| Current ratio | 7.47 | 9.29 | 8.41 | 13.25 | 17.31 |
Source: SEC EDGAR filings · CIK 0001720580 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.